Press release
Non-opioid Analgesics Market Will Generate New Growth Opportunities in Upcoming Year
Non-opioid Analgesics Market - OverviewAnalgesics refer to a term that refers to a class of drugs that are used to relieve pain without causing a loss of consciousness. Opioid analgesics have been widely adopted throughout the world and are widely recognized as the most efficient and broadly used drugs for treating severe pain. The goal of improving healthcare outcomes promotes global demand for analgesics such as pain management, which necessitates a multidisciplinary approach.
Read Report Overview @ https://www.transparencymarketresearch.com/non-opioid-analgesics-market.html
Aside from that, manufacturers' composition of opioid analgesics with abuse-deterrent properties has created a high demand for analgesics worldwide. The growing prevalence of chronic and neuropathic pain are considered key factors augmenting the sales growth of the global non-opioid analgesics market during the forecast period set between 2021 and 2031.
The Non-opioid Analgesics market is classified on the basis of drug class, indication, route of administration, distribution channel, and region. Based on drug class, the market is grouped into opioids, NAIDs, acetaminophen, and local anesthetics. With respect to indication, the market is categorized into neuropathic pain, cancer pain, surgical pain, and others. On the basis of route of administration, the market is categorized into transdermal, parenteral, oral, and others. In terms of categorization by distribution channel, the market is grouped into online pharmacies, drug stores, retail pharmacies, and hospital pharmacies.
Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=85141
The research report on Non-opioid Analgesics market provides an elaborate overview of the market and its prime growth parameters. This includes drivers, restraints, challenges, and future growth opportunities. The report also throws light on the key innovations that made positive contribution to the market in terms of revenue generation. The impact of the novel COVID19 pandemic is also discussed in the report. List of the notable players and their efforts in the form of innovations and new product launches is also discussed in details. For more information on this report, log on to the company website.
Non-opioid Analgesics Market - Competitive Landscape
The nature of competition for the global market is highly fragmented due to the presence of a multiple players. Leading players of the Non-opioid Analgesics market are using multiple strategies such as introducing innovative products to attract more revenues to the market. Other players are engaging in merger and acquisition, and joint ventures and collaborative efforts to create revenue generation opportunities for the Non-opioid Analgesics market in the coming years.
Get Table of Content of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=85141
Some of the key players of the global Non-opioid Analgesics market include:
Novartis AG
Bausch Health Companies Inc.
GlaxoSmithKline Plc.
Bayer AG
Mallinckrodt Pharmaceuticals
Assertio Therapeutics Inc.
Purdue Pharmaceuticals L.P.
Endo Pharmaceuticals Inc.
Janssen Pharmaceuticals Inc.
Johnson & Johnson
Boehringer Ingelheim International GmbH
Teva Pharmaceuticals
AbbVie Inc.
Sanofi SA
Sun Pharma
Others
Non-opioid Analgesics Market - Growth Drivers
The increasing prevalence of opioid addiction and painkiller abuse has resulted in the development of various types of abuse-deterrent technologies. Over the forecast period, the advancement of production facilities across regions with limited novel drug delivery systems will create lucrative growth opportunities for the non-opioid analgesics market. The advent of non-opioid analgesics in emerging markets where opioid and non-opioid drugs with novel drug delivery systems are not easily available for pain management opens up opportunities for the analgesics market to grow.
Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85141
Non-opioid Analgesics Market - Geographical Insights
Regionwise, this market is widespread into the regions of Latin America, Europe, North America, and the Middle East and Africa. These regions are further categorized as per the nations bringing business. North America emerged as the largest revenue generator for the Non-opioid Analgesics market owing to the presence of major players, coupled with the high recommendation of pain management drugs. Besides this, Europe and Asia Pacific markets will also generate notable revenues in the forecast period on account of the rising rate of chronic pain cases, and medical upgradation in terms of therapeutics and diagnostics.
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-opioid Analgesics Market Will Generate New Growth Opportunities in Upcoming Year here
News-ID: 2789254 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Analgesics
Key Influencer in the Analgesics Market 2025: Elevated Prevalence Of Chronic Dis …
"How Are the key drivers contributing to the expansion of the analgesics market?
The growing frequency of chronic health conditions fuels the expansion of the analgesics market. Analgesics, colloquially known as painkillers, are employed in combating extreme or long-lasting pain resulting from a variety of health disorders. For instance, a report from the World Health Organization (WHO) in September 2022 pointed out that chronic diseases, also dubbed noncommunicable diseases (NCDs), materialize…
Market Growth Opportunity in Analgesics
Global Analgesics Market: Overview
Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for…
Global Antipyretic Analgesics Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Antipyretic Analgesicsindustry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antipyretic Analgesicsand market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
GLOBAL INFO RESEARCH has recently published a research report titled, [Global Antipyretic Analgesics Market 2020 by Company, Regions, Type and Application, Forecast to…
Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the…
Analgesics Market - Global Industry Analysis 2024
Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for the consistent growth…
Global Antipyretic Analgesics Sales Market Report 2017
This report studies sales (consumption) of Antipyretic Analgesics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Crown Pharmaceuticals
Medipaams India
SRS Pharmaceuticals
Umang Pharma
YaoPharma
...
Market Segment by…
